BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/21/2021 8:44:04 AM | Browse: 259 | Download: 295
 |
Received |
|
2021-04-19 14:53 |
|
Peer-Review Started |
|
2021-04-19 14:55 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-24 08:44 |
|
Revised |
|
2021-07-03 14:05 |
|
Second Decision |
|
2021-08-24 03:19 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-08-24 09:09 |
|
Articles in Press |
|
2021-08-24 09:09 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-09-05 22:59 |
|
Typeset the Manuscript |
|
2021-10-18 02:59 |
|
Publish the Manuscript Online |
|
2021-10-21 08:44 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Case Report |
| Article Title |
Conversion therapy of hepatic artery ligation combined with transcatheter arterial chemoembolization for treating liver cancer: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Guo-Ying Feng, Yu Cheng, Xiu Xiong and Zheng-Rong Shi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Zheng-Rong Shi, PhD, Associate Chief Physician, Surgeon, Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Chongqing 400016, China. shizr@hospital.cqmu.edu.cn |
| Key Words |
Hepatic carcinoma; Conversion therapy; Surgery; Interventional therapy; Case report |
| Core Tip |
Portal vein embolization (PVE), associated liver partition and portal vein ligation for staged hepatectomy (ALPPS), and transcatheter arterial chemoembolization (TACE) are commonly used in conversion therapy of advanced liver cancer. However, the therapeutic effects of PVE and TACE are limited and ALPPS is associated with high morbidity and mortality. We therefore combined hepatic artery ligation with TACE, which has a longer treatment cycle and slower compensation of the contralateral liver compared with the above treatments, but which may make R0 resection feasible with less surgical complications and with good postoperative recovery. |
| Publish Date |
2021-10-21 08:44 |
| Citation |
Feng GY, Cheng Y, Xiong X, Shi ZR. Conversion therapy of hepatic artery ligation combined with transcatheter arterial chemoembolization for treating liver cancer: A case report. World J Clin Cases 2021; 9(30): 9151-9158 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i30/9151.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i30.9151 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
